Dysregulation of GATA3 has also been associated with other diseases, including breast cancer, where reduced GATA3 expression was linked with a poorer prognosis and unfavorable tumor phenotype (264), and where mutations in exon 6 of GATA3 were detected in >50% of tested patients. Here, GATA3 is linked to breast carcinoma.